On Friday, shares of a major drug company went through the roof, hitting the 20% upper circuit limit. The price rose after the company’s founders said they were selling a 71% stake to a group of private equity investors. The stock price rose from about ₹830 per share to almost ₹996, indicating that investors were very excited about the news and wanted to buy the company.
As buyers rushed to buy shares, trading numbers went through the roof. The stock quickly became one of the most popular and highest-gaining shares on the exchange. This shows how strongly the market reacts to changes in who owns a company.
When a promoter leaves, ownership changes
When the managers decided to sell their full stake, it changed who owned the company in a big way. The stake was bought by WaveRise Investments, ChrysCapital Fund X, and Two Infinity Partners, three private equity companies. It looks like WaveRise got about 56.45%, ChrysCapital got 10.32%, and Two Infinity Partners got 3.91 %.
The deal is estimated to be worth about ₹1,446 crore, making it one of the largest private equity deals in the Indian pharmaceutical industry over the last few years. The sale transfers control from the long-time main company to a group of investors, which means new strategy projects and operational changes are likely to occur.
The open offer adds premium and boosts mood
The new investor group had to make an open offer to buy up to 26% of the company’s shares from public owners. This was required by the government for big stock purchases. The price being offered is ₹860.64 per share, which is more than the last market price and gives buyers a bonus.
This open offer made investors even more optimistic because it showed that the group was serious about taking over a lot of the company and gave owners a good way to get out. A big distributor exit and a premium open offer were two of the main reasons why analysts said the stock hit its upper circuit limit.
Read also: Reasons Why Stock Traders Should Care About the NSE IPO
Reactions in the market and investors’ hope
Novartis India Limited was the most popular upper circuit stock, up 20%. This was mostly due to news that Novartis AG, the company that started it, will sell its 70.68% stake (17,450,680 shares) to three buyers: WaveRise Investments, ChrysCapital Fund X, and Two Infinity Partners. A big change in power like this is a big deal for businesses, and stock prices generally go up or down a lot.
Investors were happy to hear about the sale of the stake and the possibility of growth in the future under new ownership.
Experts said that this kind of market behavior happens a lot after a big change in ownership, when everyone knows how much a company is worth and what its strategic potential is. Investors rushed to buy shares because they were sure that the private equity owners could improve operations and start growth projects that would make the shares more valuable to shareholders.
Read more: Widespread selloff hits stocks as Trump’s threats over
What the Future Holds With New Ownership
The company is likely to go through a time of strategy change after the stake sale. The new owners will probably work to improve processes, add more products, and take advantage of market possibilities to help the business grow.
As a sign of the change in power, the company also plans to get rid of any references to its old parent company from its name within the next 120 days. Even though the company’s recent quarterly results showed a small drop in both sales and profit, investors are hopeful that the private equity group will bring new ideas to the table that will help the company reach its full potential.
Lastly, the statement made it clear that the companies buying the company will become its supporters. This has led to dreams of a change in the company’s board structure and a possible plan to bring it back to life.
Money matters
In Q3 FY26, the company made 86 crores from its business, compared to 93 crores in Q3 FY25. This is a drop of about 8% year over year. In the same way, the net profit in Q3 FY26 was Rs 16 crore, less than the Rs 25 crore profit in Q3 FY25.
I am a versatile content writer from the MP region, covering politics, business, crime, current affairs, entertainment, video games, and sports with clear insights, engaging analysis, and timely, reader-focused updates.
